We found significantly increased ratios of CD69 expression in MS women with respect to healthy women (cytCD56dim/CD3+CD56+CD8+, p < 0.001; cytCD56dim/regCD56bright, p = 0.06) (Figure 6). This evidence concerns the gene CD69 and myeloid sarcoma.